Related Experiment Video

Updated: May 30, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

1.6K

The complex landscape of immune dysregulation in multisystem inflammatory syndrome in children with COVID-19

Jing Guo1,2, Lie Wang1,3

  • 1Institute of Immunology and Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 311100, China.

Life Medicine
|January 28, 2025
PubMed

Insights

Multisystem inflammatory syndrome in children (MIS-C) involves immune dysregulation after SARS-CoV-2 infection. This review explores innate, T cell, and B cell immunity, and the spike protein's role in MIS-C.

Area of Science:

  • Pediatric Immunology
  • Infectious Diseases
  • Virology

Background:

  • While typically mild, SARS-CoV-2 infection can lead to severe outcomes in children, including Multisystem Inflammatory Syndrome in Children (MIS-C).
  • MIS-C presents 2-6 weeks post-infection with a hyperinflammatory state affecting multiple organs.
  • Immune responses in pediatric SARS-CoV-2 infection and MIS-C require further elucidation.

Purpose of the Study:

  • To review the immune dysregulation mechanisms in MIS-C.
  • To focus on innate, T cell, and B cell-mediated immunity in MIS-C.
  • To discuss the potential role of the SARS-CoV-2 spike protein as a superantigen in MIS-C.

Main Methods:

  • This is a review article.
  • Literature search on immune responses in MIS-C.
  • Analysis of current understanding of MIS-C pathophysiology.

Main Results:

  • Immune dysregulation involves complex interactions within innate, T cell, and B cell compartments.
  • The SARS-CoV-2 spike protein may act as a superantigen, contributing to hyperinflammation.
  • Specific immune cell subsets and cytokine profiles are altered in MIS-C patients.

Conclusions:

  • Understanding the detailed immune mechanisms in MIS-C is critical for effective treatment strategies.
  • Targeting specific immune pathways may improve outcomes for children with MIS-C.
  • Further research is needed to fully unravel the pathogenesis of MIS-C.

Keywords:
SARS-CoV-2autoantibodyimmune dysregulationmultisystem inflammatory syndrome in childrensuperantigen

More Related Videos

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.4K
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

10.2K

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
240
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
385
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
131
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
176